Cell Therapy Bioreactors Market Report 2026

Cell Therapy Bioreactors Market Overview

• Cell Therapy Bioreactors market size has reached to $1.24 billion in 2025 • Expected to grow to $2.61 billion in 2030 at a compound annual growth rate (CAGR) of 16% • Growth Driver: Growing Demand For Gene Therapies Fueling The Growth Of The Market Due To Advancements In Genetic Sequencing And Targeted Treatments • Market Trend: Accelerating Cell Therapy Bioreactors With Scalable Bioproduction, Modular Multi-Scale Platforms, And Enhanced Adherent Cell Culture Control • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Cell Therapy Bioreactors Market?

The cell therapy bioreactors are specialized systems designed to support the controlled growth, expansion, and differentiation of cells for therapeutic applications. They provide a regulated environment with precise control over factors such as temperature, pH, oxygen, and nutrient supply to maintain cell viability and functionality. By enabling scalable and reproducible cell production, these bioreactors facilitate the development and manufacturing of advanced cell-based therapies. The main products of cell therapy bioreactors are including stirred tank bioreactors, wave-induced bioreactors, fixed-bed bioreactors, and other products. Stirred tank bioreactors refer to systems where cells are cultured in a controlled liquid environment with mechanical agitation to ensure uniform growth, while wave-induced bioreactors utilize gentle rocking motion to mix cells and media. cell types, including stem cells, immune cells, differentiated cells, and others. The materials used single-use bioreactors and reusable systems bioreactors. They serve multiple applications, such as research, clinical studies, and commercial production, catering to end users including pharmaceutical and biotechnology companies, academic and research institutes, contract manufacturing organizations (CMOs), and others.

What Is The Cell Therapy Bioreactors Market Growth Forecast?

The cell therapy bioreactors market size is expected to see rapid growth in the next few years. It will grow to $2.61 billion in 2030 at a compound annual growth rate (CAGR) of 16.0%. The growth in the forecast period can be attributed to growing adoption of cell therapy bioreactors in manufacturing, rising investment in advanced bioprocessing technologies, increasing focus on process optimization and quality control, expansion of clinical trials involving cell therapies, and growing demand for personalized medicine applications. Major trends in the forecast period include advancements in automated cell culture technologies, innovations in bioreactor design for enhanced scalability, developments in stem cell expansion platforms, research and development in process monitoring and control systems, and emerging upgrades in integrated cell therapy manufacturing solutions.

Global Cell Therapy Bioreactors Market Segmentation

1) By Product: Stirred Tank Bioreactors, Wave-Induced Bioreactors, Fixed-Bed Bioreactors, Other Products 2) By Cell Type: Stem Cells, Immune Cells, Differentiated Cells, Other Cell Types 3) By Material: Single-Use Bioreactors, Reusable Bioreactors 4) By Application: Research, Clinical, Commercial Production 5) By End-Users: Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Contract Manufacturing Organizations (CMOs), Other End Users Subsegments: 1) By Stirred Tank Bioreactors: Stainless Steel Stirred Tank Systems, Glass Stirred Tank Systems, Single Use Stirred Tank Systems, Automated Stirred Tank Systems 2) By Wave Induced Bioreactors: Rocking Motion Bioreactor Systems, Single Use Wave Bag Systems, Modular Wave Platform Systems, Automated Wave Based Culture Systems 3) By Fixed Bed Bioreactors: Packed Bed Bioreactor Systems, Scaffold Based Fixed Bed Systems, Microcarrier Based Fixed Bed Systems, Perfusion Enabled Fixed Bed Systems 4) By Other Products: Hollow Fiber Bioreactor Systems, Perfusion Bioreactor Systems, Rotary Cell Culture Systems, Microfluidic Bioreactor Systems

What Are The Drivers Of The Cell Therapy Bioreactors Market?

The growing demand for gene therapies is expected to propel the growth of the cell therapy bioreactors market going forward. Gene therapy refers to a medical technique that involves modifying or replacing defective genes to treat or prevent diseases. The increasing demand for gene therapy is due to advancements in genetic sequencing and diagnostics, which enable precise identification of disease-causing genes for targeted treatment. Cell therapy bioreactors accelerate gene therapies by providing optimized environments for the growth, modification, and expansion of therapeutic cells. They enhance treatment development and scalability by ensuring consistent cell quality, improving efficiency, and supporting faster production of personalized gene-based therapies. For instance, in December 2024, according to the American Society of Gene & Cell Therapy (ASGCT), a US-based non-profit medical and scientific organization, the Food and Drug Administration (FDA) approved 6 gene therapy products in 2023, up from 5 approvals in 2022. Therefore, the growing demand for gene therapies is driving the growth of the cell therapy bioreactors industry. The increasing prevalence of chronic diseases is expected to propel the growth of the cell therapy bioreactors market going forward. Chronic and rare diseases refer to long-term health conditions and uncommon disorders that often require specialized treatment approaches, including personalized and regenerative therapies. Chronic diseases are increasing largely due to unhealthy lifestyles, including poor diet, physical inactivity, and smoking, which raise the risk of conditions such as diabetes, heart disease, and obesity. Cell therapy bioreactors support chronic disease management by providing controlled environments for the cultivation and expansion of therapeutic cells. They enhance treatment effectiveness and scalability by ensuring consistent cell quality, enabling personalized therapies, and supporting long-term patient care. For instance, in 2025, according to the International Diabetes Federation, a Belgium-based health organization, in 2024, around 589 million adults aged 20-79 were living with diabetes, with the total number projected to reach 853 million by 2050. Therefore, the increasing prevalence of chronic and rare diseases is driving the growth of the cell therapy bioreactors industry.

Key Players In The Global Cell Therapy Bioreactors Market

Major companies operating in the cell therapy bioreactors market are Thermo Fisher Scientific Inc., Merck KGaA, FUJIFILM Holdings Corporation, Danaher Corporation, Corning Incorporated, Lonza Group, Terumo Corporation, Sartorius AG, Eppendorf AG, Miltenyi Biotec B.V. & Co. KG, PBS Biotech Inc., Meissner Filtration Products Inc., Infors AG, Bionet Engineering & Technologies Pvt. Ltd., Wilson Wolf Manufacturing Corporation, Synthecon Incorporated, Cellexus Limited, Celartia Inc., Able Biott Inc., CelVivo ApS

Global Cell Therapy Bioreactors Market Trends and Insights

Major companies operating in the cell therapy bioreactors market are focusing on developing advancing platforms, such as modular, multi-scale bioreactor platforms, to improve process scalability, cell expansion efficiency, and consistency from early research through commercial manufacturing. A modular multi-scale bioreactor platform refers to a flexible system that enables researchers to conduct parallel small-scale experiments, optimize conditions, and seamlessly scale up to mid- or large-scale production while maintaining uniform culture conditions and high yields. For instance, in July 2024, EXO-Harvest, a Belgium-based biomanufacturing technology company, launched its cutting-edge multi-scale bioreactor platform for efficient manufacturing of mesenchymal stem cells and extracellular vesicles, supporting scalable adherent cell culture from discovery to industrial production. The platform includes small-scale multi-bioreactor screening and mid/large-scale systems designed to accelerate development, reduce costs, and deliver high-quality cultures with precise environmental control

Regional Insights

North America was the largest region in the cell therapy bioreactors market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Cell Therapy Bioreactors Market?

The cell therapy bioreactors market consists of sales of bioreactor vessels, control systems, single-use bioreactor units, perfusion bioreactors, and monitoring and automation equipment. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Cell Therapy Bioreactors Market Report 2026?

The cell therapy bioreactors market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the cell therapy bioreactors industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.